BBR Partners Portfolio holdings
BBR Partners is a multi-family office that advises high net worth families and individuals, and it may spread their money across a range of outside investment managers and strategies. It was founded in 2000 by Brett Barth, Arthur Black and Evan Roth, all former Goldman Sachs executives; Roth had also run private accounts at Global Asset Management. Barth and Roth share the chief executive role and are the principal controllers of the firm's holding company. The firm does due diligence on the managers it hires, and it runs its own BBR Funds that pool client money in diversified portfolios of alternative and other investments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ellington Financial
EFC
|
+$5.79M |
| 2 |
JUNO
Juno Therapeutics, Inc.
JUNO
|
+$4.99M |
| 3 |
Apple
AAPL
|
+$2.89M |
| 4 |
Procter & Gamble
PG
|
+$2.31M |
| 5 |
Schwab International Equity ETF
SCHF
|
+$2.23M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.55M |
| 2 |
Albemarle
ALB
|
+$893K |
| 3 |
AVTA
Avantax, Inc. Common Stock
AVTA
|
+$605K |
| 4 |
Goldman Sachs
GS
|
+$346K |
| 5 |
POT
Potash Corp Of Saskatchewan
POT
|
+$308K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 39.07% |
| 2 | Consumer Staples | 35.8% |
| 3 | Technology | 10.03% |
| 4 | Healthcare | 5.59% |
| 5 | Real Estate | 3.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
State Street SPDR S&P 500 ETF Trust
SPY
$800B
| $190M | 35.72% |
713,466
-21,325
| -3% | -$5.55M |
2013 Q2
18 quarters
|
|
2
Brown-Forman Class A
BF.A
$14.5B
| $171M | 32.09% |
3,179,715
| – | – |
2013 Q2
18 quarters
|
|
|
ATVI
3
DELISTED
Activision Blizzard
ATVI
| $43.4M | 8.13% |
685,145
+505
| +0.1% | +$31.9K |
2015 Q4
8 quarters
|
|
4
Humana
HUM
$54B
| $23.8M | 4.47% |
96,050
| – | – |
2015 Q4
8 quarters
|
|
|
5
Ellington Financial
EFC
$1.44B
| $17.5M | 3.29% |
1,208,757
+380,000
| +46% | +$5.79M |
2013 Q2
18 quarters
|
|
6
Brown-Forman Class B
BF.B
$14.1B
| $11.7M | 2.19% |
265,494
+31
| +0% | +$1.18K |
2013 Q2
18 quarters
|
|
7
Black Stone Minerals
BSM
$3.03B
| $9.35M | 1.75% |
521,080
| – | – |
2015 Q4
8 quarters
|
|
|
KMF
8
DELISTED
Kayne Anderson NextGen Energy & Infrastructure, Inc.
KMF
| $5.69M | 1.07% |
412,369
| – | – |
2015 Q3
9 quarters
|
|
|
9
Apple
AAPL
$5.18T
| $4.66M | 0.87% |
110,124
+69,128
| +169% | +$2.89M |
2014 Q2
14 quarters
|
|
|
JUNO
10
DELISTED
Juno Therapeutics, Inc.
JUNO
| $4.57M | 0.86% |
+100,000
| New | +$4.99M |
2017 Q4
0 quarters
|
|
11
ExxonMobil
XOM
$696B
| $4.38M | 0.82% |
52,384
-1,636
| -3% | -$135K |
2013 Q2
18 quarters
|
|
12
Coca-Cola
KO
$427B
| $3.76M | 0.7% |
81,874
+28
| +0% | +$1.29K |
2016 Q1
7 quarters
|
|
13
Gartner
IT
$12.1B
| $3.48M | 0.65% |
28,219
+140
| +0.5% | +$17K |
2015 Q4
8 quarters
|
|
|
14
Procter & Gamble
PG
$394B
| $3.2M | 0.6% |
34,861
+25,663
| +279% | +$2.31M |
2016 Q1
7 quarters
|
|
|
15
Schwab International Equity ETF
SCHF
$67.8B
| $2.23M | 0.42% |
+131,142
| New | +$2.23M |
2017 Q4
0 quarters
|
|
16
Amazon
AMZN
$2.88T
| $2.2M | 0.41% |
+37,540
| New | +$2.07M |
2017 Q4
0 quarters
|
|
17
Schwab US Large-Cap Value ETF
SCHV
$15.8B
| $2M | 0.38% |
+109,734
| New | +$1.95M |
2017 Q4
0 quarters
|
|
18
iShares MSCI ACWI ETF
ACWI
$32.6B
| $1.98M | 0.37% |
+27,487
| New | +$1.94M |
2017 Q4
0 quarters
|
|
19
Vanguard Morningstar Small-Cap Value ETF
VBR
$37.5B
| $1.98M | 0.37% |
+14,908
| New | +$1.94M |
2017 Q4
0 quarters
|
|
20
Berkshire Hathaway Class A
BRK.A
$1.26T
| $1.79M | 0.34% |
6
| – | – |
2013 Q2
18 quarters
|
|
21
Boeing
BA
$136B
| $1.57M | 0.3% |
5,337
+674
| +14% | +$182K |
2016 Q2
6 quarters
|
|
22
Meta Platforms (Facebook)
META
$1.64T
| $1.33M | 0.25% |
7,518
+4,865
| +183% | +$860K |
2013 Q2
18 quarters
|
|
|
23
Albemarle
ALB
$11B
| $1.24M | 0.23% |
9,731
-6,587
| -40% | -$893K |
2015 Q1
11 quarters
|
|
24
PepsiCo
PEP
$198B
| $1.16M | 0.22% |
9,656
-275
| -3% | -$31.4K |
2013 Q2
18 quarters
|
|
25
CF Industries
CF
$18.3B
| $852K | 0.16% |
20,027
+27
| +0.1% | +$1.02K |
2016 Q3
5 quarters
|
|
Similar funds
BBR Partners's Q4 2017 Portfolio in Review
As of Q4 2017, BBR Partners held 82 positions worth $533M, up 14% from $470M the previous quarter. Its ten largest holdings account for 90% of the portfolio.
BBR Partners deployed $20.8M of net new capital in Q4 2017, opening 13 new positions and adding to 15 existing holdings. Its largest new stake was Juno Therapeutics, Inc.: 100,000 shares worth $4.57M.
By sector, the portfolio is most concentrated in Miscellaneous at 39% of assets, down from 41% a quarter earlier, followed by Consumer Staples and Technology.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $5.55M trimmed.
- BBR Partners's largest Q4 2017 buy was Juno Therapeutics, Inc.: 100,000 shares worth $4.57M.
- BBR Partners added most to Ellington Financial in Q4 2017, an estimated $5.79M increase.
- BBR Partners's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.55M.
- BBR Partners fully exited Avantax, Inc. Common Stock in Q4 2017, selling an estimated $605K.
- BBR Partners's ten largest holdings make up 90% of its $533M portfolio in Q4 2017.
- BBR Partners opened 13 new positions and closed 9 in Q4 2017.
- BBR Partners's portfolio value rose 14% quarter-over-quarter to $533M.
Based on BBR Partners's 13F filing for Q4 2017, filed 8 Feb 2018.